{
    "clinical_study": {
        "@rank": "82313", 
        "arm_group": [
            {
                "arm_group_label": "Pregabalin", 
                "arm_group_type": "Active Comparator", 
                "description": "Single, 150 mg pre-operative oral dose of Pregabalin"
            }, 
            {
                "arm_group_label": "Sugar Pill", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Single, placebo pre-operative dose"
            }
        ], 
        "brief_summary": {
            "textblock": "Pregabalin 150mg or placebo are administered 1 hour preoperatively in patients undergoing\n      partial hepatectomy. Postoperatively, patients receive morphine as rescue analgesic.\n      Morphine consumption in the first 48 hours is documented. Postoperative pain is measured by\n      the visual analogue scale (VAS) score."
        }, 
        "brief_title": "Preoperative Pain Control in Liver Surgery Patients", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pain, Postoperative", 
            "Hepatocellular Carcinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Pain, Postoperative", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "detailed_description": {
            "textblock": "Methods: In this Randomized Controlled Trial, patients undergoing partial hepatectomy will\n      be administered a single pre-operative dose of Pregabalin or a placebo. Primary endpoints\n      are as follows:\n\n        -  Post-operative analgesic requirements\n\n        -  Post-operative VAS scale (rated 0-10)\n\n        -  Complications\n\n        -  Post-operative antiemetic requirement\n\n        -  Length of stay"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients undergoing partial hepatectomy\n\n        Exclusion Criteria:\n\n          -  contraindication against pregabalin\n\n          -  creatinine > 2.0 mg/dl\n\n          -  GGT >165, AST >105, ALT >135\n\n          -  peptic Ulcus\n\n          -  haemorrhagic diathesis\n\n          -  angina pectoris, myocardial infarction\n\n          -  stroke\n\n          -  bronchial asthma\n\n          -  opioid abuse"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01923948", 
            "org_study_id": "EHBHKY2013-001-09"
        }, 
        "intervention": [
            {
                "arm_group_label": "Pregabalin", 
                "description": "One 150 mg oral dose of Pregabalin given before surgery", 
                "intervention_name": "Pregabalin", 
                "intervention_type": "Drug", 
                "other_name": "Lyrica"
            }, 
            {
                "arm_group_label": "Sugar Pill", 
                "description": "One oral dose of placebo given before surgery", 
                "intervention_name": "Placebo (for Pregabalin)", 
                "intervention_type": "Drug", 
                "other_name": "Sugar pill manufactured to mimic Pregabalin 150 mg tablet"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Pregabalin", 
                "Gamma-Aminobutyric Acid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hepatocellular carcinoma", 
            "Hepatectomy", 
            "randomized controlled trials(RCTs)", 
            "Postoperative Pain"
        ], 
        "lastchanged_date": "February 21, 2014", 
        "location": {
            "contact": {
                "email": "yinlei409@hotmail.com", 
                "last_name": "yin lei, MD", 
                "phone": "0086-021-81875534"
            }, 
            "contact_backup": {
                "email": "ajli62@gmail.com", 
                "last_name": "li ai jun, MD", 
                "phone": "0086-021-81875531"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "zip": "200438"
                }, 
                "name": "Eastern Hepatobiliary Surgery Hospital"
            }, 
            "investigator": {
                "last_name": "yin lei, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Placebo-Controlled Study of Whether Pre-operative Pregabalin 150 mg Will Improve Pain Control in Patients With Hepatocellular Carcinoma Undergoing Partial Hepatectomy", 
        "overall_contact": {
            "email": "yinlei409@hotmail.com", 
            "last_name": "yin lei, MD", 
            "phone": "0086-021-81875534"
        }, 
        "overall_contact_backup": {
            "email": "ajli62@gmail.com", 
            "last_name": "li ai jun, MD", 
            "phone": "0086-021-81875531"
        }, 
        "overall_official": {
            "affiliation": "Eastern Hepatobiliary Surgery Hospital, Second Military Medical University", 
            "last_name": "li ai jun, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Postoperative Opioid Consumption", 
            "safety_issue": "No", 
            "time_frame": "48 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01923948"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Eastern Hepatobiliary Surgery Hospital", 
            "investigator_full_name": "ShenFeng", 
            "investigator_title": "vice president of the Eastern Hepatobiliary Surgery Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Postoperative Pain Scores on the Visual Analog Scale", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "source": "Eastern Hepatobiliary Surgery Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Eastern Hepatobiliary Surgery Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}